Evidence map›Paper›PMID 33281536›Full record

ArticleFood & nutrition research2020

Yang Li, Xin Jiang, Hongjian Xu, Jingyi Lv, Guangning Zhang, Xiujing Dou, Yonggen Zhang, Xiaoxiang Li

Open access · goldAbstract read
In one paragraph

Article in Food & nutrition research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Alleviating Effects of Ethanol Extract fromAntioxidants (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Immunopharmacological Insights intoCurrent pharmaceutical design · 2025
    Review
  5. Review
  6. Article
  7. Effects ofAntioxidants (Basel, Switzerland) · 2024
    Article
  8. The genome and transcriptome ofFrontiers in cellular and infection microbiology · 2023
    Article
  9. Effects of dietaryJournal of animal science and technology · 2022
    Article
  10. Antioxidants (Basel, Switzerland) · 2022
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yang LiCollege of Animal Science and Technology, Northeast Agricultural University, Harbin, China.
Xin JiangCollege of Animal Science and Technology, Northeast Agricultural University, Harbin, China.
Hongjian XuCollege of Animal Science and Technology, Northeast Agricultural University, Harbin, China.
Jingyi LvCollege of Animal Science and Technology, Northeast Agricultural University, Harbin, China.
Guangning ZhangCollege of Animal Science and Technology, Northeast Agricultural University, Harbin, China.
Xiujing DouCollege of Animal Science and Technology, Northeast Agricultural University, Harbin, China.
Yonggen ZhangCollege of Animal Science and Technology, Northeast Agricultural University, Harbin, China.
Xiaoxiang LiMicrobial Biological Engineering Company Limited, Hefei, China.
Northeast Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAs a major disease affecting dairy cow production worldwide, bovine mastitis is caused by a variety of pathogenic microorganisms that eventually cause mammary gland inflammation. Acremonium terricola culture (ATC) is a new type of affordable feed additive produced by the solid fermentation of A. terricola isolated from

objectivesTo evaluate the protective effects of ATC on mastitis and investigate its active mechanism, a lipopolysaccharide (LPS)-induced rat mastitis model was used in two experiments.

designIn Experiment 1, a total of 40 female Sprague-Dawley rats were used to determine the optimal supplementary dose of ATC via gavage trial. In Experiment 2, we examined the effects of an optimal dose of ATC on LPS-induced mastitis in rats.

resultsThe results of Experiment 1 showed that administration of ATC improved growth performance and antioxidant functions in the serum and the liver, as well as immunoglobulin A, G, and M levels in rat serum, and it decreased the content of alanine aminotransferase, aspartate aminotransferase, triglyceride, cholesterol, low-density lipoprotein, and serum urea nitrogen in rat serum; a dosage of 250-1,250 mg/kg/day was shown to be high enough to be effective. The results of Experiment 2 indicated that ATC can relieve the inflammatory reaction of mammary glands in rats, and the LPS-induced expression of tumor necrosis factor-α, interleukin-1β, interleukin-6, and inducible nitric oxide synthase significantly decreased after ATC treatment. Moreover, our results demonstrated that ATC markedly enhanced the activity of antioxidase in this rat mastitis model. The results of Western blot analysis revealed that ATC could suppress the expression of toll-like receptor 4, phosphorylation of extracellular signal-regulated kinase, and activity of c-Jun N-terminal kinase in the LPS-stimulated mastitis model.

conclusionTaken together, ATC was shown to exert its anti-inflammatory effect by blocking mitogen-activated protein kinase signaling pathways. These results demonstrate that ATC exerts anti-inflammatory and antioxidant effects in mastitis prevention.

Indexed as

Acrermonium terricola cultureanti-inflammationantioxidantmastitis

Identifiers

PMID33281536
PMCPMC7681784
OpenAlexW3103661873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.